Page 9 - Pathogen Readiness News Today

HMS Dean Outlines Financial, Institutional Goals in State of the School Address | News | The Harvard Crimson

In the three months since Johnson & Johnson’s COVID-19 vaccine received emergency use authorization from the U.S. Food and Drug Administration, more than 10 million Americans have received the vaccine, according to the Centers for Disease Control and Prevention. The single-shot viral vector vaccine — developed in collaboration with Beth Israel Deaconess Medical Center (BIDMC) immunologist Dan Barouch — was authorized for use based on clinical trial data showing strong clinical efficacy ag...

This article is part of Harvard Medical School's continuing coverage of medicine, biomedical research, medical education, and policy related to the...

BOSTON – In the three months since Johnson & Johnson's COVID-19 vaccine received emergency use authorization from the U.S. Food and Drug Administration,...

Harvard holds its first virtual alumni association annual meeting—with a powerful guest speaker.

Scientific American How COVID Changed Science What is unprecedented is not just the speed and focus with which the community responded to the pandemic but also the singular willingness of scientists all over the world to share new ideas and data immediately and transparently Advertisement Rarely in recent memory has the world faced such an immediate and widespread global threat as complex as COVID-19. In its face, a select few have risen to the occasion, none more cherished and admired perhaps...

POLICY In the COVID-19 crisis, rival institutions joined forces. Can those collaborations endure? by Bruce Walker It is now possible to imagine a world recovered from COVID-19. In that future, how will medicine have changed? These 10 essays explore the technical, social and political ripples of the pandemic. On March 2, 2020, within days of the first reported cases of COVID-19 in the United States, a group of about 100 physicians and scientis...

Newswise — Boston – Pregnant women with symptomatic COVID-19 have a higher risk of intensive care unit admissions, mechanical ventilation and death compared to non-pregnant reproductive age women. Increases in preterm birth and still birth have also been observed in pregnancies complicated by the viral infection. The Centers for Disease Control and Prevention (CDC) recommended that people who are pregnant may choose to be vaccinated at their own discretion with their healthcare provider. Ho...

This figure presents serum binding and functional antibody responses following COVID-19 vaccination and SARS-CoV-2 infection among women 45 years or younger. A and B, Each panel compares vaccine antibody responses at 2 through 8 weeks after the second dose to nonpregnant and pregnant women who were unvaccinated and infected. Thirteen women (7 nonpregnant, 4 pregnant, and 2 lactating) who had baseline samples collected within 7 days of their first vaccine dose were selected based on the earliest...

 E-Mail Boston - Pregnant women with symptomatic COVID-19 have a higher risk of intensive care unit admissions, mechanical ventilation and death compared to non-pregnant reproductive age women. Increases in preterm birth and still birth have also been observed in pregnancies complicated by the viral infection. The Centers for Disease Control and Prevention (CDC) recommended that people who are pregnant may choose to be vaccinated at their own discretion with their healthcare provider. However,...